Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat Stroke | 1 | 2016 | 2 | 0.490 |
Why?
|
| Malignant Hyperthermia | 1 | 2016 | 5 | 0.490 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 23 | 0.480 |
Why?
|
| Physical Exertion | 1 | 2016 | 80 | 0.470 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 250 | 0.400 |
Why?
|
| Dopamine | 4 | 2008 | 106 | 0.170 |
Why?
|
| Parkinsonian Disorders | 2 | 2008 | 15 | 0.140 |
Why?
|
| Drowning | 1 | 2017 | 3 | 0.130 |
Why?
|
| Resuscitation | 1 | 2016 | 67 | 0.120 |
Why?
|
| Triage | 1 | 2016 | 134 | 0.110 |
Why?
|
| Neurons | 3 | 2008 | 932 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 987 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1568 | 0.090 |
Why?
|
| Corpus Striatum | 2 | 2008 | 98 | 0.080 |
Why?
|
| Brain Tissue Transplantation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2008 | 9 | 0.070 |
Why?
|
| Levodopa | 1 | 2008 | 9 | 0.070 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2008 | 15 | 0.070 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 27 | 0.070 |
Why?
|
| Neuritis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Risk Factors | 2 | 2016 | 5392 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1136 | 0.070 |
Why?
|
| Neprilysin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 68 | 0.070 |
Why?
|
| Plaque, Amyloid | 1 | 2007 | 41 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 154 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2008 | 135 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2008 | 622 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 271 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 275 | 0.060 |
Why?
|
| Young Adult | 1 | 2016 | 4772 | 0.060 |
Why?
|
| Rats | 4 | 2008 | 1990 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2008 | 718 | 0.050 |
Why?
|
| Humans | 4 | 2017 | 64768 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 762 | 0.040 |
Why?
|
| Aged | 1 | 2016 | 14882 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2007 | 832 | 0.040 |
Why?
|
| Mesencephalon | 2 | 2008 | 28 | 0.040 |
Why?
|
| Oxidopamine | 2 | 2008 | 6 | 0.040 |
Why?
|
| Water Wells | 1 | 2017 | 1 | 0.030 |
Why?
|
| Rivers | 1 | 2017 | 22 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 249 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 260 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 86 | 0.030 |
Why?
|
| Male | 1 | 2016 | 30840 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 2019 | 0.030 |
Why?
|
| Animals | 5 | 2008 | 21264 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1382 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 2274 | 0.020 |
Why?
|
| Microdialysis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2008 | 12 | 0.020 |
Why?
|
| Enkephalins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Antiparkinson Agents | 1 | 2008 | 10 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2008 | 22 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Wnt-5a Protein | 1 | 2008 | 8 | 0.020 |
Why?
|
| Parthenogenesis | 1 | 2008 | 9 | 0.020 |
Why?
|
| Neuroepithelial Cells | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nestin | 1 | 2008 | 13 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Neostriatum | 1 | 2008 | 26 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2008 | 85 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2008 | 37 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 23 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2008 | 5 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2008 | 14 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2008 | 7 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 77 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2008 | 29 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2008 | 90 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2008 | 104 | 0.020 |
Why?
|
| Transplants | 1 | 2007 | 8 | 0.020 |
Why?
|
| Graft Survival | 1 | 2008 | 296 | 0.020 |
Why?
|
| Gliosis | 1 | 2007 | 27 | 0.020 |
Why?
|
| Astrocytes | 1 | 2008 | 122 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 168 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 103 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 202 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 192 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 282 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 362 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 586 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 449 | 0.020 |
Why?
|
| Female | 4 | 2008 | 33804 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 710 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 428 | 0.010 |
Why?
|
| Motor Activity | 1 | 2008 | 343 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 701 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 2008 | 227 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 895 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 319 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 623 | 0.010 |
Why?
|
| Microglia | 1 | 2008 | 250 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1035 | 0.010 |
Why?
|
| Mice | 2 | 2008 | 11071 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1286 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2187 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1574 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1628 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2007 | 912 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3467 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 5765 | 0.010 |
Why?
|